banner ad

RSSCategory: Financial News

GenOsteo and SpineSmith to take UTSA’s first licensed technology to market

Akillas | March 14, 2011 | 0 Comments
GenOsteo and SpineSmith to take UTSA’s first licensed technology to market

By Christi Fish Public Affairs Specialist (March 4, 2011)–San Antonio-based GenOsteo Inc. and Austin-based SpineSmith Partners announce an agreement to commercialize a synthetic scaffold that can be used with adult stem cells (ASCs) to produce a new and highly effective bone graft material. The scaffold, developed by biomedical engineers at The University of Texas at [...]

Continue Reading

Orthovita Reports 2010 Fourth Quarter and Year-End Financial Results and Provides 2011 Financial Guidance

Akillas | March 14, 2011 | 0 Comments
Orthovita Reports 2010 Fourth Quarter and Year-End Financial Results and Provides 2011 Financial Guidance

MALVERN, Pa.–(BUSINESS WIRE)–Orthovita, Inc. (NASDAQ: VITA), a specialty spine and orthopedic company with a portfolio of orthobiologic and biosurgery products, reported financial results for the quarter and year ended December 31, 2010. Product sales for the quarter ended December 31, 2010 decreased 4% to $23.4 million compared to $24.4 million for the same period in [...]

Continue Reading

J&J Says DePuy Orthopaedics President David Floyd Resigns

Akillas | March 14, 2011 | 0 Comments

By Alex Nussbaum – Mar 5, 2011 12:21 AM GMT+0200 Johnson & Johnson (JNJ) said David Floyd is resigning as worldwide president of DePuy Orthopaedics, the maker of artificial hips and knees that has struggled with product recalls and lawsuits over faulty implants. Floyd, president of the unit since 2007, submitted his resignation last week [...]

Continue Reading

AxioMed Spine Further Funded by Ohio Loan

Akillas | March 4, 2011 | 0 Comments

AxioMed Spine, which manufactures artificial disc replacements for medical patients, received $500,000 in the form of a loan from the state of Ohio to continue developing an artificial cervical spine disc. The company has raised $56 million to date from investors including Siemens Venture Capital GmbH, Aisling Capital, Fidelity Biosciences, Kearny Venture Partners and OrbiMed [...]

Continue Reading